About Casdin Capital
Casdin Capital is a Healthcare company. Investing in Life Sciences sectors like Healthcare and Biotechnology. It operates in the Healthcare and Agriculture sectors. Casdin Capital has completed 1 acquisition, including Singular Genomics. Casdin Capital offers products and services including Investment Services and Venture Funding. Its focus areas include Life Sciences, Biotechnology, Drug Developers and Therapeutics.
Company details
Casdin Capital is identified as an investor in the dynamic Life Sciences field, covering Healthcare, Biotechnology, Synthetic Biology, and Technology. Positions are built by partnering with companies that leverage molecular information for innovations in diagnostics and therapies. Emphasis is placed on patience, persistence, and values such as excellence and integrity, while opportunities are explored in areas like gene therapies and data platforms. The firm is noted for its expertise in navigating ethical and scientific challenges, contributing to advancements that address global demands.
- SectorsHealthcareAgriculture
- Email••••••••
- Phone•••• ••••
- Website casdincapital.com
- Legal Name Casdin Capital
- Investments & Acquisitions
Products & Services of Casdin Capital
Casdin Capital offers a comprehensive portfolio of products and services, including Investment Services and Venture Funding.
Investing is conducted in healthcare innovations and molecular medicine to support paradigm shifts in disease identification and treatment
Funding is provided for biotechnology and synthetic biology companies to advance tools, diagnostics, and therapies
People of Casdin Capital
19 people are tracked at Casdin Capital (5 in leadership, 9 in board & advisors, 5 in team).
| Name | Role | Group |
|---|---|---|
Eli Casdin | Chief Investment Officer & Founder | Leadership |
Randy White | Director of Business Development & Investor Relations | Leadership |
Scott Bryan | Head of Technology | Leadership |
Brad Weisgerber | Head Trader | Leadership |
Shana P. | Executive Assistant To Founder & Chief Investment Officer | Leadership |
Alex Parker | Advisor | Board & advisors |
William G. Kaelin | Advisor | Board & advisors |
Alan Huang | Advisor | Board & advisors |
Kevin O’brien | Advisor | Board & advisors |
Carlos Garcia-Echeverria | Advisor | Board & advisors |
Eric Olson | Advisor | Board & advisors |
Catherine Brisson | Advisor | Board & advisors |
Kiran Musunuru | Advisor | Board & advisors |
Alley Olshansky | Advisor | Board & advisors |
David Bozkurtian | Business Systems Engineer | Team |
Caroline Hegarty | Executive Assistant | Team |
Yi Chi Song | Associate | Team |
Carress Brown | Investor Relations Associate | Team |
John Graziano | Platform Investor Relations & Syndication Lead | Team |
Complete people profiles for Casdin Capital
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Casdin Capital
Casdin Capital has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Singular Genomics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Next-generation gene sequencing and multi-omics technologies are provided. | singulargenomics.com | San Diego, United States | 2016 | Aug 2021 | •••• |
Complete acquisition details for Casdin Capital
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Casdin Capital
Complete news archive for Casdin Capital
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Casdin Capital
Casdin Capital is identified as an investor in the dynamic Life Sciences field, covering Healthcare, Biotechnology, Synthetic Biology, and Technology. Positions are built by partnering with companies that leverage molecular information for innovations in diagnostics and therapies. Emphasis is placed on patience, persistence, and values such as excellence and integrity, while opportunities are explored in areas like gene therapies and data platforms. The firm is noted for its expertise in navigating ethical and scientific challenges, contributing to advancements that address global demands.
Casdin Capital offers Investment Services and Venture Funding.
Casdin Capital has made 1 acquisition, including Singular Genomics.
Casdin Capital operates through Casdin Capital.